Status:
UNKNOWN
Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study
Lead Sponsor:
Universidade Federal do Rio de Janeiro
Conditions:
Keratoconus
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
Cross-linking of the cornea increases the mechanical and biochemical stability of the stromal tissue. The purpose of this study is to assess the effectiveness of riboflavin-ultraviolet light induced c...
Eligibility Criteria
Inclusion
- Age from 18 to 35 years.
- Diagnosis of Keratoconus.
- Progression of Ametropia.
- Written informed consent.
Exclusion
- Corneal Thickness \< 395 micra at thinnest point.
- Other active ocular disease than keratectasia.
- Cornea Guttata.
- Previous ocular surgery.
- Pregnancy.
- Known sensitivity to riboflavin.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00642044
Start Date
February 1 2007
End Date
December 1 2009
Last Update
April 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clementino Fraga Filho University Hospital
Rio de Janeiro, Rio de Janeiro, Brazil, 21941-913